Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

HIF-1α influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination

Open access
Bhandari, Tamara, Olson, Joshua, Johnson, Randall S., Nizet, Victor · 2013 · Journal of Molecular Medicine

Abstract

Hypoxia-inducible factor (HIF)-1 is a transcription factor known to play an important role in regulating the innate immune response to infection. Under baseline conditions, cellular HIF-1 levels in leukocytes are scarce, but levels rise rapidly in response to hypoxia or molecular signals of infection or inflammation such as microbial surface molecules and host-derived cytokines. Innate immune cells such as macrophages, neutrophils, and mast cells exhibit increased microbicidal activity when HIF-1 levels are increased, and mice lacking HIF-1 are more susceptible to invasive bacterial infection. In this study, we used genetic and pharmacologic means to determine whether HIF-1 also plays an important role in the adaptive immune response to infection. HIF-1α/Tie-2 Cre(+) mice harboring a >90 % knockdown of HIF-1 in myeloid cells were studied. We found antigen-presenting cells from these mice that expressed lower levels of MHC-II and the costimulatory molecules CD80 and CD86, and were less able to induce T cell proliferation. These differences were present at baseline and persisted after activation. Increasing HIF-1 levels in wild-type (WT) cells by using the prolyl hydroxylase inhibitor drug AKB-4924 had the opposite effect, increasing MHC and costimulatory molecule expression and T cell proliferation. In experimental vaccination, HIF-1α/Tie-2 Cre(+) mice exhibited a weaker T cell response and lower antibody levels in response to vaccination than WT mice, while WT mice treated with a drug to elevate HIF-1 responded more strongly to vaccination. Thus, HIF-1 participates in bridging the innate and adaptive immune responses and may merit further exploration as an adjuvant target.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00109-013-1052-y

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 54

Metadata

Authors
Bhandari, T., Olson, J., Johnson, R. S., & Nizet, V.
Affiliations
  • University of California San Diego (US)
  • University of Cambridge (GB)
Corresponding author
Nizet, Victor
Venue
Journal of Molecular Medicine
Published
2013-05-19
Volume
91
Issue
10
Pages
1199-1205
ISSN
  • 0946-2716 (ISSN-L)
  • 1432-1440
OpenAlex
W2113299134
Cited by
47
References
34
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 6 · 2020: 8 · 2019: 1 · 2018: 4 · 2017: 3 · 2016: 6 · 2015: 4 · 2014: 8
FWCI
3.32
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Wellcome Trust (092738/Z/10/Z, 092738)
  • National Institutes of Health
  • U.S. Public Health Service (T32 062496, 093451, T32 007752, 090863)
  • University of California, San Diego
  • National Institute of General Medical Sciences (T32GM007752)
  • National Institute of Allergy and Infectious Diseases (R01AI093451, R56AI090863)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR062496)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords
HIF-1α, myeloid cells, antigen presentation, MHC class II, costimulatory molecules, CD80, CD86, T cell proliferation, prolyl hydroxylase inhibitors, innate-adaptive immune crosstalk, vaccine adjuvants, hypoxia
MeSH terms
Animals, Dendritic Cells, Immunity, Innate, Injections, Subcutaneous, Lymphocyte Activation, Macrophages, Ovalbumin, Piperazines, Pyridones, Vaccination, T-Lymphocyte Subsets, Cytokines, Antigen Presentation, Mice, Knockout, Myeloid Cells, Mice, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIF-1α influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination. https://app.cochat.ai/papers/10.1007/s00109-013-1052-y
The paper
Bhandari, T., Olson, J., Johnson, R. S., & Nizet, V. (2013). HIF-1α influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-013-1052-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.